Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $810000.0.

  • Haemonetics' Exchange Rate Effect rose 11303.93% to $810000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $7.0 million, marking a year-over-year increase of 21353.15%. This contributed to the annual value of -$685000.0 for FY2025, which is 7849.29% up from last year.
  • As of Q4 2025, Haemonetics' Exchange Rate Effect stood at $810000.0, which was up 11303.93% from -$773000.0 recorded in Q3 2025.
  • Haemonetics' 5-year Exchange Rate Effect high stood at $4.6 million for Q4 2022, and its period low was -$6.2 million during Q4 2024.
  • Its 5-year average for Exchange Rate Effect is -$423400.0, with a median of -$720000.0 in 2021.
  • Examining YoY changes over the last 5 years, Haemonetics' Exchange Rate Effect showed a top increase of 105344.47% in 2022 and a maximum decrease of 163167.7% in 2022.
  • Haemonetics' Exchange Rate Effect (Quarter) stood at -$667000.0 in 2021, then surged by 784.71% to $4.6 million in 2022, then plummeted by 33.85% to $3.0 million in 2023, then crashed by 305.63% to -$6.2 million in 2024, then skyrocketed by 113.04% to $810000.0 in 2025.
  • Its Exchange Rate Effect stands at $810000.0 for Q4 2025, versus -$773000.0 for Q3 2025 and $4.2 million for Q2 2025.